Diabetes, Newly Diagnosed and Monitoring Panel

Use

This panel provides a comprehensive evaluation of key laboratory parameters in patients newly diagnosed with diabetes or during routine monitoring, aligning with American Diabetes Association (ADA) recommendations. It includes fasting glucose and hemoglobin A1c for glycemic control, fasting lipid profile for cardiovascular risk assessment, liver function tests for hepatic health, urinary albumin excretion (including spot urine albumin-to‑creatinine ratio) for nephropathy screening, and serum creatinine with estimated glomerular filtration rate (eGFR) for kidney function monitoring ([questdiagnostics.com](https://www.questdiagnostics.com/healthcare-professionals/about-our-tests/diabetes-pre-diabetes/newly-diagnosed-monitoring-panel?utm_source=openai)).